MedPal AI (LSE:MPAL) Asset Impairment Charge: £ Mil (TTM As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is MedPal AI Asset Impairment Charge?

MedPal AI LSE:MPAL -4.76% Asset Impairment Charge is £ Mil as of Feb. 2026. The stock has 1 warning sign investors should review.

MedPal AI's Asset Impairment Charge for the six months ended in Feb. 2026 was £ Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2026 was £ Mil.

MedPal AI Asset Impairment Charge Related Terms

MedPal AI Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for MedPal AI's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedPal AI Asset Impairment Charge Chart

MedPal AI Annual Data
Trend Aug22 Aug23 Aug24 Aug25
Asset Impairment Charge
- - - -

MedPal AI Semi-Annual Data
Feb24 Aug24 Feb25 Aug25 Feb26
Asset Impairment Charge - - - - -

MedPal AI Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £ Mil.

What does a Asset Impairment Charge of £ Mil mean?
MedPal AI (LSE:MPAL) has a Asset Impairment Charge of £ Mil as of Feb. 2026.
Is MedPal AI's Asset Impairment Charge too high?
MedPal AI's current Asset Impairment Charge is £ Mil.
How does MedPal AI's Asset Impairment Charge compare to VEEV and BTSG?
MedPal AI's Asset Impairment Charge of £ Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Healthcare Providers & Services company?
A good Asset Impairment Charge depends on the Healthcare Providers & Services industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. MedPal AI's current Asset Impairment Charge is £ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Asset Impairment Charge of £ Mil. The current Asset Impairment Charge is £ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Asset Impairment Charge is £ Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedPal AI Business Description

Other Exchanges Z1N:Germany
Address 71 Queen Victoria Street, Floor 8, London, GBR, EC4V 4AY
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.